Q&A: Albireo’s Ron Cooper on bile acid modulationWhile bile acids might not be as trendy as gene editing, modulating them has potential for first-in-class therapies Share XQ&A: Albireo’s Ron Cooper on bile acid modulationhttps://pharmaphorum.com/r-d/views-analysis-r-d/qa-albireos-ron-cooper-on-bile-acid-modulation/
